TFC Financial Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.72K Hold
34
﹤0.01% 507
2025
Q4
$2.9K Hold
34
﹤0.01% 492
2025
Q3
$2.65K Hold
34
﹤0.01% 523
2025
Q2
$2.66K Buy
34
+6
+21% +$447 ﹤0.01% 481
2025
Q1
$2.03K Buy
28
+3
+12% +$215 ﹤0.01% 489
2024
Q4
$1.85K Buy
25
+7
+39% +$490 ﹤0.01% 510
2024
Q3
$1.19K Sell
18
-25
-58% -$1.82K ﹤0.01% 566
2024
Q2
$3.97K Buy
43
+5
+13% +$443 ﹤0.01% 409
2024
Q1
$3.63K Buy
38
+3
+9% +$252 ﹤0.01% 411
2023
Q4
$2.67K Sell
35
-8
-19% -$557 ﹤0.01% 426
2023
Q3
$2.98K Sell
43
-1
-2% -$80 ﹤0.01% 427
2023
Q2
$4.15K Sell
44
-195
-82% -$16.9K ﹤0.01% 384
2023
Q1
$19.8K Buy
239
+213
+819% +$16.7K 0.01% 316
2022
Q4
$1.94K Buy
26
+8
+44% +$617 ﹤0.01% 404
2022
Q3
$1K Hold
18
﹤0.01% 470
2022
Q2
$2K Hold
18
﹤0.01% 400
2022
Q1
$2K Hold
18
﹤0.01% 416
2021
Q4
$2K Hold
18
﹤0.01% 464
2021
Q3
$2K Hold
18
﹤0.01% 452
2021
Q2
$2K Hold
18
﹤0.01% 444
2021
Q1
$2K Hold
18
﹤0.01% 434
2020
Q4
$2K Hold
18
﹤0.01% 427
2020
Q3
$1K Buy
+18
New +$1.4K ﹤0.01% 455

Other funds holding EW

TFC Financial Management's EW Position: Q1 2026 in Review

TFC Financial Management held its Edwards Lifesciences (EW) position steady in Q1 2026 at 34 shares worth $2.72K. The position accounts for ﹤0.01% of the portfolio, ranked #507.

TFC Financial Management first reported a position in EW in Q3 2020 and has held it in 23 quarters since. The position peaked at $19.8K in Q1 2023. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • TFC Financial Management held 34 shares of Edwards Lifesciences worth $2.72K as of Q1 2026.
  • TFC Financial Management left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up ﹤0.01% of TFC Financial Management's portfolio in Q1 2026, its #507 holding.
  • TFC Financial Management first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 23 quarters since.
  • TFC Financial Management's Edwards Lifesciences position peaked at $19.8K in Q1 2023.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on TFC Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.